Received by email:

File: Abattis - News Release Laraque Agreement.DOC



ABATTIS SIGNS GEORGES LARAQUE MANAGEMENT INC. 
AS MEDIA AND PRODUCT CHAMPION 

Vancouver, BC - January 7, 2013 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU
--->), announces the engagement of Georges Laraque Management Inc. effective January 1, 2013. Georges Laraque Management I
--->nc. will be assisting the Company in Marketing and Branding  all of the Natural Health Products designed by Abattis . 
--->As partial consideration for Georges Laraque Management Inc. entering into this agreement and providing services  ther
--->eunder, the Company agreed to issue 150,000 shares of the Company at a deemed price of $0.10/share. The shares will be
---> subject to a 4 month hold period as required by applicable securities laws.

Mr. Mike Withrow, Chief Executive Officer on behalf of the Company, stated, "We are pleased to have Mr. Laraque join o
--->ur Abattis team. His professionalism and dedication to his political beliefs as Deputy Leader of the Green Party of Ca
--->nada and his work done in Haiti, and PETA spokesperson,  along with being Vegan, he has demonstrated during his career
--->  not only does have  the ability but passion and drive and will help Abattis and its brands to be recognized and resp
--->ected in political arenas, Athletic Performance Markets, Vegan Nutrition, and Animal Wellness Markets." 

 Mr Georges Laraque, Retired NHL Star and current Deputy Leader of the Green Party of Canada and Spokes Person for PET
--->A stated, I am very excited about this opportunity to work with such a great company and be able to further my support
---> in the Natural Health Products arena, I see Abattis as a well poised company with advanced Pharmaceutical Grade Verti
--->cal Farming, Packaging and Extraction technologies to ensure people safety with the purest compounds with complete tra
--->ceability from A-Z and I look forward to helping this company grow.   


About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiarie
--->s of producing, licensing and marketing proprietary ingredients and bio-similar compounds for use in Pharmaceuticals, 
--->Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products rea
--->dy for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company
--->'s website at www.abattis.com. 

ON BEHALF OF THE BOARD


					
Michael Withrow, President & CEO



Neither the CNSX Exchange nor its regulations services accepts responsibility
for the adequacy or accuracy of this release.